Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis
- Supplementary File 1:
PDF-Document (PDF, 462 KiB)
Quint, T.; Brunner, P.M.; Sinz, C.; Steiner, I.; Ristl, R.; Vigl, K.; Kimeswenger, S.; Neubauer, K.; Pirkhammer, D.; Zikeli, M.; Hoetzenecker, W.; Reider, N.; Bangert, C. Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis. J. Clin. Med. 2020, 9, 1241. https://doi.org/10.3390/jcm9041241
Quint T, Brunner PM, Sinz C, Steiner I, Ristl R, Vigl K, Kimeswenger S, Neubauer K, Pirkhammer D, Zikeli M, Hoetzenecker W, Reider N, Bangert C. Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis. Journal of Clinical Medicine. 2020; 9(4):1241. https://doi.org/10.3390/jcm9041241
Chicago/Turabian StyleQuint, Tamara; Brunner, Patrick M.; Sinz, Christoph; Steiner, Irene; Ristl, Robin; Vigl, Kornelia; Kimeswenger, Susanne; Neubauer, Katharina; Pirkhammer, Detlev; Zikeli, Martin; Hoetzenecker, Wolfram; Reider, Norbert; Bangert, Christine. 2020. "Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis" J. Clin. Med. 9, no. 4: 1241. https://doi.org/10.3390/jcm9041241